Search

everythinglearnresearchcommunity

for

Search:↓

Patients with long COVID after Omicron had fewer hospitalizations and milder symptoms but more fatigue, insomnia, and cough compared to those with Delta.

The document concludes that Passiflora incarnata may help with anxiety, healthcare workers need mental support, common bacteria cause hospital UTIs, telehealth for heart failure needs research, kids' screen time has increased, pregnant teens are mostly okay with their body image, diagnosing post-surgery tuberculosis is hard, older and severely ill people are more likely to have long COVID symptoms, and psychiatrists should be part of pain management teams.

Platelet-Rich Plasma therapy helped significantly in hair recovery for a hair loss condition after infection.

Children's screen time increased during the pandemic, causing various health issues.

Surgery to fix a broken upper arm bone can sometimes lead to nerve damage.

People with cleft lip and palate often have respiratory problems.

Pharmacists play a key role in managing the use of anxiety medications and ensuring patients use them correctly.

Skin problems in COVID-19 patients are rare and may be due to the body's complex immune response or blood clotting issues.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

Insulin resistance linked to obesity may increase COVID-19 severity.

Vitamin D supplements significantly improved post-COVID-19 symptoms in deficient patients.

People who had severe COVID-19 are more likely to experience hair loss.

Most skin issues were due to COVID-19, with some caused by vaccines or treatments, and were categorized into five types.

Eating plant-based anti-inflammatories and antioxidants may help manage long-term COVID-19 health issues.

Men with androgenetic alopecia and hypertension may experience more severe COVID-19.

Covid-19 can cause hair loss due to immune and psychological factors.

Patients treated in Respiratory Intensive Care Units for COVID-19 are more likely to get mood disorders than those in other care settings.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

COVID-19 may cause early hair loss similar to classic temporary hair loss, with further research needed.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

The COVID-19 quarantine in Turkey disrupted dermatological care, increased stress-related skin issues, and showed the need for psychological support and teledermatology.

Hydroxychloroquine may help COVID-19 patients with lupus.

Patients with lupus nephritis and COVID-19 can improve with proper treatment.

Men are more likely to have severe COVID-19 cases and fatalities than women due to factors like lifestyle, aging, and biological differences.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

People with diabetes or obesity should manage their conditions carefully as they have a higher risk of severe COVID-19.

COVID-19 may harm male fertility and damage the reproductive system.

COVID-19 can cause various skin issues, including rashes and hair loss, which usually heal on their own and don't always indicate severe illness.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

The conclusion is that certain genetic factors and blood types may affect COVID-19 severity, but changes in ACE2 and TMPRSS2 genes are not clearly linked to it.